Clinical Diagnostics

Selected news for the healthcare topic - Clinical Diagnostics, collected since 10/2017. Recent stories appear in rnrmarketresearch.com and markets.co. This healthcare topic shares news with Siemens, Thermo Fisher, Food and Drug Administration, COVID-19, Siemens Healthineers and hundreds of others.

Please provide a valid email address.

Selected Headines

Date Headline (link) Source Relevant Snippet
2/22/2021 Global Bone Mineral Testing Market Growth (Status and Outlook) 2021-2026 rnrmarketresearch.com 11.5.2 Roche Bone & Mineral Testing Product Offered 11.5.3 Roche Bone & Mineral Testing Revenue, Gross Margin and Market Share (2019-2021) 11.5.4 Roche Main Business Overview 11.5.5 Roche Latest Developments 11.6.1 Siemens Healthcare Company Information 11.6.2 Siemens Healthcare Bone & Mineral Testing Product Offered 11.6.3 Siemens Healthcare Bone & Mineral Testing Revenue, Gross Margin and Market Share (2019-2021) 11.6.4 Siemens Healthcare Main Business Overview 11.6.5 Siemens Healthcare Latest Developments 11.7 Bio-Rad Laboratories 11.7.1 ...
2/22/2021 Morgan Stanley Sticks to Their Hold Rating for Invitae (NVTA) markets.co ... Monday at $48.87.According to TipRanks.com , Savant is a 4-star analyst with an average return of 23.7% and a 68.4% success rate. Savant covers the Healthcare sector, focusing on stocks such as Ortho Clinical Diagnostics Holdings, Pacific Biosciences, and NanoString Tech.Invitae has an analyst consensus of Moderate Buy, with a price target consensus of $56.00, representing a 13.9% upside. In a report issued on February 17, Oppenheimer also ...
2/22/2021 Asia: DKSH acquires in Korea and Singapore laingbuissonnews.com ... is headquartered in Seoul, Korea and employs around 90 specialists. The company sells, markets and distributes consumables as well as scientific instrumentation from an international client portfolio, used in the fast-growing life sciences, clinical diagnostics , environmental, and microbiology markets. Their customer base includes hospitals, research institutes, laboratories, universities, pharma as well as food and beverage companies.“We have been present in Korea for 30 years and are delighted to ...
2/19/2021 Demand for Immunochemicals Slumps Temporarily amid Covid-19 Outbreak, Fact.MR Study express-press-release.net ... Country, 2021-Feb-19 — /EPR Network/ —Immunochemical offerings are largely reliant on luminometric, fluoro, and photon-based detection. These products have gained traction as the healthcare sector transitions away from chromatography in clinical diagnostics .Faster detection of disease-specific antibodies, and diagnostics in terms of pharmaceuticals, hormones, and biomarkers will aid growth in the long term. Also, applications in environment analysis, food safety assessment, and targeted chemical structures ...
2/17/2021 The Bioinformatics Market is Expected to Reach $13.50 Billion in 2023 with CAGR of 14.5% portlandnews.net ... and by sector, medical biotechnology segment is expected to grow at the highest rate during the forecast period.Growing demand for nucleic acid and protein sequencing, applications of bioinformatics in proteomics and drug discovery, clinical diagnostics and personalized medicine are the major factors driving the growth of the bioinformatics market. On the other hand, lack of well-defined standards and common formats for data integration are the major factor restraining ...
2/17/2021 In-Vitro Diagnostics Market Status and Development Trends 2027 Wordpress.com ... produce high quality, low-cost reagents.Immunoassays will grow with a significant share during the forecast period. The large share of this segment is mainly attributed to the increasing preference for these technologies in clinical diagnostics over other traditional methods.In-vitro diagnostics are often used for a wide range of applications in hospitals and clinics. A continuous upward trend in the number of diseases like diabetes, hypertension, kidney inflammation ...
2/17/2021 Ortho Clinical Diagnostics Announces Rating Upgrades by S&P Global and Moody's gurufocus.com Agencies Provide Stable Outlook Following Company’s Initial Public Offering RARITAN, N.J., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc ( OCDX) ("Ortho"), one of the world's largest pure-play in vitro diagnostics companies, today announced that S&P Global (“S&P”) upgraded Ortho’s issuer credit rating to “B” from “B-” and Moody’s investment Services (“Moody’s”) upgraded Ortho’s Corporate Family Rating ...
2/16/2021 Eurofins Forensics Adds Significant COVID-19 Testing Capacity to the UK With Home Testing Roll-Out | Business & Finance | heraldchronicle.com Business Wire ... together its UK laboratories across multiple disciplines to work together to facilitate increased direct to consumer COVID-19 testing, significantly increasing the UK’s current testing capacity.The combined resources of Eurofins Forensics, Eurofins Clinical Diagnostics and Eurofins Food & Water Testing will facilitate up to 350,000 tests per week, made available to the general public via home test kits.The move will see nearly 300 employees working 24/7 to process ...
2/16/2021 We Are Still Doing Enough Tests Says Health Dg babab.net ... done to detect positive cases. Although there has been a decrease in PCR tests, more RTK-Ag tests are being done,” he said.He added that the health ministry would use PCR tests for clinical diagnostics of patients and RTK-Ag kits for on-field testing.He also said the drop in PCR tests might be due to a lack of manpower over the festive season and fewer people getting tested ...
2/16/2021 DALLAS, TX / ACCESSWIRE / February 16, 2021 / Acco wapakdailynews.com ... and by sector, medical biotechnology segment is expected to grow at the highest rate during the forecast period.Growing demand for nucleic acid and protein sequencing, applications of bioinformatics in proteomics and drug discovery, clinical diagnostics and personalized medicine are the major factors driving the growth of the bioinformatics market. On the other hand, lack of well-defined standards and common formats for data integration are the major factor restraining ...
2/16/2021 The Ridgway Record ridgwayrecord.com ... and by sector, medical biotechnology segment is expected to grow at the highest rate during the forecast period.Growing demand for nucleic acid and protein sequencing, applications of bioinformatics in proteomics and drug discovery, clinical diagnostics and personalized medicine are the major factors driving the growth of the bioinformatics market. On the other hand, lack of well-defined standards and common formats for data integration are the major factor restraining ...
2/16/2021 Eurofins Forensics Adds Significant COVID-19 Testing Capacity to the UK With Home Testing Roll-Out financialbuzz.com ... together its UK laboratories across multiple disciplines to work together to facilitate increased direct to consumer COVID-19 testing, significantly increasing the UK’s current testing capacity.The combined resources of Eurofins Forensics, Eurofins Clinical Diagnostics and Eurofins Food & Water Testing will facilitate up to 350,000 tests per week, made available to the general public via home test kits.The move will see nearly 300 employees working 24/7 to process ...
2/14/2021 Head-To-Head Contrast: Luminex (NASDAQ:LMNX) versus GenMark Diagnostics (NASDAQ:GNMK) Mayfield Recorder ... nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; FlowSight Imaging Flow cytometer; ImageStream System; CellStream Flow Cytometer; Guava easyCyte line; and Muse Cell Analyzer. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite ...
2/12/2021 Engineering's Anant Madabhushi named to two scientific panels case.edu ... website.Madabhushi also joined the recently formed Scientific Advisory Board for artificial intelligence-based software company Aiforia. He comes to the panel as one of four advisors recognized for their “world-class expertise in clinical diagnostics , personalized medicine, digital and computational pathology.” As an advisor, Madabhushi will work with Aiforia in their goal of pioneering cutting-edge AI tools to convert medical imaging into practical data. Learn more about ...
2/11/2021 Antimicrobial Susceptibility Testing Market worth $4.2 billion by 2025 mnmblog.org ... segment is attributed to the presence of regulatory guidelines to streamline the process of antibacterial susceptibility testing, technological advancements, and the rising burden of antibacterial resistance in developing as well as developed countries. The clinical diagnostics segment is expected to register the highest growth rate during the forecast period Based on application, the antimicrobial susceptibility testing market has been segmented into the market is segmented into clinical diagnostics , drug discovery ...
2/11/2021 Antimicrobial Susceptibility Testing Market worth $4.2 billion by 2025 marketsandmarketsblog.com ... segment is attributed to the presence of regulatory guidelines to streamline the process of antibacterial susceptibility testing, technological advancements, and the rising burden of antibacterial resistance in developing as well as developed countries. The clinical diagnostics segment is expected to register the highest growth rate during the forecast period Based on application, the antimicrobial susceptibility testing market has been segmented into the market is segmented into clinical diagnostics , drug discovery ...
2/11/2021 Bio-Rad Laboratories: Q4 Earnings Insights Benzinga ... mmc/p/8cfv55c7Technicals 52-week high: $648.39Company's 52-week low was at $309.38 9.79%Company Overview Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (60% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), the firm develops and ...
2/10/2021 Immuno Oncology Assays Market To Reach USD 5.9 Billion By 2024 - Size, Share, Developments, Opportunities PRSync ... Immuno Oncology Assays Market . The research applications segment accounted for the largest share of the market in 2018. On the basis of application, the Immuno-Oncology Assays Market is segmented into research applications and clinical diagnostics . Research applications dominated the market with the largest share in 2018. It is also projected to be the fastest-growing segment during the forecast period. The rising prominence of biomarker-based drug development and ...
2/10/2021 VA physicians collected liver tissue from 'seriously ill' patients without consent Washington Examiner ... collection of liver sample biopsies violated protocol and "put patients at increased risk of bleeding and pain."In April 2018, the whistleblowers alleged to the VA facility leadership that biopsy samples intended only for clinical diagnostics were taken for research purposes from nine participants.The allegations prompted the San Diego Healthcare System to initiate an institutional review board that "did not substantiate these allegations," though the board said the additional ...
2/10/2021 Stable Isotope Labelled Compounds Market Report 2021-2031 visiongain.com 10 February 2021 Pharma Stable Isotope Labelled Compounds : Forecasts by Type (Carbon 13, D, Oxygen 18, N15), Application (Research, Clinical Diagnostics , Industrial), End User (Pharmaceutical & Biopharmaceutical Companies, Academic institute). PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Analysis. PLUS COVID-19 Recovery Scenarios.GlobalStable Isotope labelled Compounds market was 2020 2031. The growth of this market is driven predominantly by the upsurge in research activities in the pharmaceutical and ...